Table of Contents
<< Previous Issue | Oct 2010 (Vol: 2010, Issue: 8) | Next Issue >> |
- Section: Cartoons
-
Fridge
- Section: Distribution & Marketing
-
Orexigen Finds Partner for Obesity Drug Prior to Regulatory Approval Decision
- Section: Joint Venture
-
Roche Strengthens CNS Pipeline with reMYND Alliance
- Section: Licensing
-
Novartis Acquires Option to Phase II siRNA Drug from Quark Pharmaceuticals
-
Onyx Pharmaceuticals Out-Licenses Japanese Rights to Proteasome Inhibitors
-
Shire Licenses Rights to Duchenne Muscular Dystrophy Drug Candidate from Acceleron
-
Abbott Pays Top Dollar to License Phase II Chronic Kidney Disease Therapy from Reata Pharmaceuticals
- Section: Mergers & Acquisitions
-
Johnson & Johnson Plans to Enter Vaccines Market via Crucell Acquisition
-
Pfizer Acquires FoldRx to Broaden its Orphan Drug Portfolio
-
Endo to Acquire Qualitest and Expand its Generics Portfolio
-
Sun Pharma Finally Acquires Controlling Stake in Taro
- Section: Research & Development
-
Roche Collaborates with Aileron to Develop Stapled Peptide Therapeutics